According to him, the industry must address its relationship with the capital markets, address misinformation issues, and push back against the politicization of medical research and development.

Cumming Group, the largest independent provider of project and cost management advisory services in North America and a market leader in Europe, announced the merger of RGD Project Management, Inc.

The long-time pharma exec is on a quest with a new book and bold message for biotech leaders and U.S. lawmakers.

LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing ...

Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.

Healthcare Investors lagged its benchmark as biotech faced regulatory hurdles and market rotation. Read the full analysis for ...

The Food and Drug Administration's top drug official is stepping down in the latest shake-up at the powerful health agency.

ZYCUBO approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $205 milli ...

Alphabet-backed Isomorphic Labs has raised $2.1 billion to expand its AI drug discovery platform and advance medicines into ...

Stifel upgrades RXO to buy from hold Stifel said its sees "idiosyncratic levers" for the asset-light transportation company. ...

Steering the FDA back to a place of regulatory steadiness and certainty won’t be easy, Bloomberg Opinion columnist Lisa Jarvis writes.

Overview: Isomorphic Labs secured a $2.1 billion Series B round to expand AI-driven drug discovery, clinical programs, and ...